Table 2

Characteristics of studies included in the meta-analysis for Alzheimer’s disease

First author; year and countryCohort and sample sourceSex; % womenBaseline age (mean (SD) or range)Follow-up time (SD) and rate (%)AD criteriaSample sizeIncident casePA typeAmount of PA (unit)Adjusted confoundersMulti-adjusted RR (95% CI)
For qualitative and quantitative analysis
Scarmeas6 ;2009; USAWHICAP; community
dwelling elders
C; 69%77.2 (6.6)5.4 (3.3); 85%NINCDS-ADRDA criteria52071LTPAMedian 0 hours/weekCohort, age, sex, ethnicity, education, APOE status, caloric intake, BMI, smoking status, depression, leisure activities, a comorbidity index and baseline CDR score1 (reference)
65084Median 0.1 hours/week of vigorous, 0.8 hours/week of moderate or 1.3 hours/week of light PA, or a combination thereof0.71 (0.51 to 0.98)
71069Median 1.3 hours/week of vigorous, 2.4 hours/week of moderate or 3.8 hours/week of light PA, or a combination thereof0.63 (0.45 to 0.90)
Ravaglia14 ;2008; ItalyCSBA; population
based study
C; 53.5%73.2 (6.0)3.9 (0.7); 94%NINCDS-ADRDA criteria25021Mixed PA<4774 kcal/weekAge, gender, education, and APOE genotype, cardiovascular disease, hypertension and hyperhomocysteinaemia, basic activities of daily living motor disability1 (reference)
249204774–8090 kcal/week0.95 (0.50 to 1.80)
25013>8090 kcal/week0.70 (0.33 to 1.49)
Podewils15 ;2005; USACHCS; community
dwelling elders
C; 59.1%74.8 (4.9)5.2; 94%NINCDS-ADRDA criteria84469LTPA<248 kcal/weekAge, educational level, gender, ethnicity, APOE4, baseline 3MSE score, MRI white matter grade score, ADL impairment, IADL impairment, LSN score and social support score1
(reference)
5.4; 94%84270248–742 kcal/week1.07 (0.73 to 1.57)
5.5; 94%84458743–1657 kcal/week0.92 (0.62 to 1.39)
5.6; 94%84348>1657 kcal/week0.70 (0.44 to 1.13)
Laurin7; 2001; CanadaCSHA; community
dwelling elders
C; 60%65 (+)5; 72%NINCDS-ADRDA criteria118380LTPANo regular PAAge, sex and educational level1 (reference)
50621Other typesC: 0.67 (0.39 to 1.14)
W: 0.70 (0.33 to 1.49)
M: 0.87 (0.26 to 2.90)
141252≥3 times/week at an intensity equal to walking (based on the MET table, the MET of ordinary walking=2.5 METs)C: 0.67 (0.46 to 0.98)
W: 0.87 (0.51 to 1.48)
M: 0.61 (0.25 to 1.50)
74716≥3 times/week at an intensity greater than walkingC: 0.50 (0.28 to 0.90)
W: 0.27 (0.08 to 0.90)
M: 0.73 (0.27 to 1.98)
Only for qualitative meta-analysis
Neergaard10; 2016; DenmarkPERF I study; RCT databaseW; 100%70.1–75.1 (4.9–6.4)11.9 (3.9); 94%ICD10155081Mixed PANoneAge, education, BMI, smoking, alcohol, vascular factors and neural disorders1 (reference)
109748Once/week0.84 (0.58 to 1.20)
67435Twice/week0.99 (0.66 to 1.47)
1849863+ times/week1.00 (0.73 to 1.37)
Andel8; 2008; SwedenSTR; National Swedish twin registryC; 61%48.1 (5.0)31.3; 70%NINCDS-ADRDA criteria35735LTPAHardly any exerciseAge, gender, education, smoking, alcohol consumption, portion of fruits and vegetables in diet, BMI and angina pectoris1 (reference)
31.5; 70%2217138Light exercise such as walking or light gardening0.64 (0.41 to 1.00)
31.6; 70%2996Regular exercise involving sports0.34 (0.14 to 0.86)
31.4; 70%22318Hard physical training0.65 (0.33 to 1.29)
Akbaraly37; 2009; FranceThree City Study; population
based study
C; 61%73.6–78 (5.3–5.7)4 (maximum); 92.3%NINCDS-ADRDA criteria259197Mixed PALow (score<2)Gender, educational level, occupational grade, study centre, marital status, hypertension, diabetes, vascular diseases history, hypercholesterolaemia, depressive symptoms, APOE genotype, incapacity in daily life activity, and cognitive impairment assessed by MMSE1 (reference)
1373Mild (score=2)0.87 (0.50 to 1.51)
1734High (score>2)1.29 (0.80 to 2.09)
Abbott9;2004; USAHAAS; population
based study
M; 100%84 (75–98)4.7; NANINCDS-ADRDA criteria60030Leisure
time walking
<0.25 miles/dayAge, APOE4, baseline CASI score, decline in PA since mid-adulthood, physical performance score, education, BMI, childhood years spent living in Japan, status as a skilled
professional, hypertension, diabetes, prevalent coronary heart disease, and total and HDL cholesterol
2.21 (1.06 to 4.57)
769390.25–1 miles/day1.86 (0.91 to 3.79)
433211–2 miles/day1.88 (0.87 to 4.04)
45511>2 miles/day1 (reference)
  • 3MSE, Modified Mini-Mental State Examination; ADL, activities of daily living; APOE, apolipoprotein E; BMI, body mass index; C, combined; CASI, Cognitive Abilities Screening Instrument; CDR, Clinical Dementia Rating; CHCS, Cardiovascular Health Cognition Study; CSBA, Conselice Study of Brain Ageing; CSHA, Canadian Study of Health and Ageing; HAAS, Honolulu–Asia Ageing Study; HDL, high density lipoprotein; IADL, instrumental activities of daily living; ICD10, International Classification of Diseases,10th revision; LSN, Lubben Social Network; LTPA, leisure time physical activity; MET, metabolic equivalent of task; MMSE, Mini-Mental State Examination; NA, not accessible; NINCDS-ADRDA, National Institute of Neurological Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association; O, original result; PA, physical activity; PERF I, Prospective Epidemiologic Risk Factor; RCT, randomised controlled trial; STR, Swedish Twin Registry; T, result after data transformation; WHICAP, Washington Heights-Inwood Columbia Ageing Project.